Edition:
United States

Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

123.20USD
9 Dec 2016
Change (% chg)

$-0.28 (-0.23%)
Prev Close
$123.48
Open
$123.82
Day's High
$128.79
Day's Low
$122.96
Volume
1,387,998
Avg. Vol
1,352,683
52-wk High
$196.47
52-wk Low
$119.37

Latest Key Developments (Source: Significant Developments)

Illumina appoints Sam Samad as senior VP and CFO
Wednesday, 7 Dec 2016 06:30am EST 

Illumina Inc: Illumina extends management team, appoints Sam A. Samad as senior vice president and chief financial officer .Sam A. Samad will join company on January 6, 2017.  Full Article

Illumina increases size of board from eight to nine members
Thursday, 28 Jul 2016 04:30pm EDT 

Illumina Inc : Effective as of july 27, 2016, board of directors increased size of board from eight to nine members - sec filing Further company coverage: [ILMN.O] (Bengaluru Newsroom: +1-646-223-8780).  Full Article

Illumina reports Q2 adj. earnings $0.86/shr
Tuesday, 26 Jul 2016 04:05pm EDT 

Illumina Inc : Illumina reports financial results for second quarter of fiscal year 2016 . Q2 non-GAAP earnings per share $0.86 . Q2 GAAP earnings per share $0.82 . Sees Q3 2016 revenue $625 million to $630 million . Q2 revenue $600 million versus I/B/E/S view $593.1 million . Sees FY 2016 non-GAAP earnings per share $3.48 to $3.58 . Sees FY 2016 revenue up about 12 percent .Q2 earnings per share view $0.73 -- Thomson Reuters I/B/E/S.  Full Article

Enzo Biochem says Enzo Life Sciences reached settlement with Illumina that included payment of $21 mln to Enzo
Thursday, 7 Jul 2016 08:01am EDT 

Enzo Biochem Inc : Co's unit, Enzo Life Sciences, has reached and finalized a settlement with Illumina that included a payment of $21 million to enzo . Settlement resolving dispute between Enzo Life Sciences and Illumina impacts only one of 11 cases originally brought by enzo .Settlement related to action brought in delaware court by Enzo alleging infringement of patent.  Full Article

Illumina received a product approval certificate for MiSeqDx instrument
Monday, 9 May 2016 04:05pm EDT 

Illumina Inc :Received a product approval certificate for Miseqdx Instrument and Miseqdx universal kit with MFDS in South Korea.  Full Article

Illumina Files Patent Infringement Suit in Switzerland against Genoma SA
Thursday, 21 Apr 2016 04:05pm EDT 

Illumina:Says co and unit Verinata Health, Inc. (together "Illumina"), filed a patent infringement suit against Genoma SA in the Federal Patent Court in Switzerland.Illumina is seeking all available remedies, including damages and injunctive relief. The patents asserted are European Patent (CH) 2 183 693 B1, European Patent (CH) 0 994 963 B2, European Patent (CH) 1 981 995 B1, and European Patent (CH) 2 514 842.The patents are directed to using cell-free fetal DNA for non-invasive prenatal testing (NIPT).Tranquility NIPT service uses the IONA(reg) Test sold by Premaitha Health plc. Illumina previously filed separate suits against Premaitha in the United Kingdom for sale of the IONA Test.  Full Article

Illumina Inc says Francis Desouza appointed president and CEO
Monday, 7 Mar 2016 04:05pm EST 

Illumina Inc:Says Jay Flatley to assume role of executive chairman of the board of directors of Illumina; Francis Desouza appointed president and CEO.Says Francis Desouza, currently president, will be appointed president and chief executive officer.  Full Article

Illumina sues Oxford Nanopore for Patent Infringement
Tuesday, 23 Feb 2016 04:05pm EST 

Illumina:That the company filed lawsuits against Oxford Nanopore Technologies Ltd. and Oxford Nanopore Technologies, Inc. (ONT).The lawsuits were filed concurrently with the U.S. International Trade Commission and in the U.S. District Court for the Southern District of California.Illumina is seeking all available remedies.  Full Article

Biomerieux and Illumina launch Biomerieux EpiSeq
Sunday, 13 Dec 2015 07:00pm EST 

Biomerieux SA:Announced with Illumina the launch of Biomerieux EpiSeq, an next-generation sequencing (NGS) service for epidemiological monitoring and control of healthcare-associated infections.  Full Article

Illumina Inc announces new $250 million share repurchase authorization
Monday, 2 Nov 2015 06:30am EST 

Illumina Inc:Announces new $250 million share repurchase authorization.Says completed repurchase of $96 million under previous share repurchase program.  Full Article

Illumina wins dismissal of Scripps Institute patent lawsuit

A federal judge in San Diego has dismissed a lawsuit by the non-profit Scripps Research Institute accusing Illumina Inc of infringing a patent related to a type of genetic analysis tool.